Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT03435705
Eligibility Criteria:
Inclusion Criteria:
* Patients with dementia (regardless of etiology) diagnosed or suspected by their physician (general practitioner or specialist) and referred to an Alzheimer specialized team
* Patients with Mini Mental State Examination score\> 15
* Patients living at home, in residences for the elderly
* Presence of a non-professional primary caregiver
Exclusion Criteria:
* Patients under 18 years of age;
* Institutionalized or foster care patients;
* Patients who routinely refuse home care;
* Patients with a known severe and unstable general pathology that does not allow patient follow-up;
* Patients already enrolled in another non-drug management trial other than the study;
* Patients whose institutionalization is probable in the short term (within 6 months) or for whom a change of domicile envisaged in the short term and would not allow the carrying out of the follow-up evaluations;
* Patients under tutorship or curatorship, patients unable to express consent;
* Primary caregiver who does not wish to participate in the study or who cannot be available for the follow-up planned for the study;
* Known cognitive deficits or chronic psychosis that do not able patients' follow-up;
* Presence of a primary caregiver with known cognitive or psychiatric disorders (chronic active psychosis) , which doesn't allow the proper conduct of the study;
* Patients who have already benefited from the "occupational" therapy program.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03435705
Study Brief:
Protocol Section:
NCT03435705